Document ID: chunk:federal_register_of_legislation:F2021L01162:reg:7
Version: federal_register_of_legislation:F2021L01162
Segment Type: reg
Provision Reference: reg 7
Character Range: 1710–3251

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about fibrosing interstitial lung disease and death from fibrosing interstitial lung disease.
Meaning of fibrosing interstitial lung disease
(2)          For the purposes of this Statement of Principles, fibrosing interstitial lung disease:
(a)          means a diverse group of lung diseases characterised by progressive fibrosis of the pulmonary interstitium with or without chronic inflammation; and
(b)          excludes:
(i)            bronchiolitis obliterans organising pneumonia;
(ii)         desquamative interstitial pneumonia;
(iii)       hypersensitivity pneumonitis (also known as extrinsic allergic alveolitis);
(iv)        pulmonary manifestations of systemic diseases; and
(v)          respiratory bronchiolitis-associated interstitial lung disease.
            Note: Clinical features typically include shortness of breath, chronic cough, restrictive pattern on lung function tests and impaired diffusing capacity of the lungs for carbon monoxide. Radiographic imaging reveals variable patterns of interstitial fibrosis.
Death from fibrosing interstitial lung disease
(3)          For the purposes of this Statement of Principles, fibrosing interstitial lung disease, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's fibrosing interstitial lung disease.
Note: terminal event is defined in the Schedule 1 - Dictionary.